Vanessa Eulo

Vanessa Eulo
Assistant Professor

Year	Title	Altmetric
2023	Genomic patterns of malignant peripheral nerve sheath tumor (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA.. Cancer Discovery. 2023
2022	Truly Man's Best Friend: Canine Cancers Drive Drug Repurposing in Osteosarcoma. Clinical Cancer Research. 28:571-572. 2022
2022	Immune checkpoint inhibitor resistance in soft tissue sarcoma 2022
2021	A randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition in metastatic soft tissue sarcoma.. Journal of Clinical Oncology. 39:tps11583-tps11583. 2021
2021	Phase II trial of pegylated arginine deiminase in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.. Journal of Clinical Oncology. 39:11508-11508. 2021
2020	A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy. European Journal of Cancer. 137:1-9. 2020
2020	Secondary Sarcomas: Biology, Presentation, and Clinical Care.. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting. 40:1-12. 2020
2018	Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST. Oncotarget. 9:23018-23028. 2018

Private Grant awarded by AYALA PHARMACEUTICALS, INC.

Private Grant awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^

Private Grant awarded by COGENT BIOSCIENCES INC

Private Grant awarded by CHECKMATE PHARMACEUTICALS INC

Doctor of Medicine, Rush University 2015

Vanessa Eulo